UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Buys 551,838 Shares of Clarivate Plc (NYSE:CLVT)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in shares of Clarivate Plc (NYSE:CLVT - Free Report) by 112.9% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,040,426 shares of the company's stock after purchasing an additional 551,838 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned 0.15% of Clarivate worth $7,387,000 as of its most recent SEC filing.

Other large investors have also made changes to their positions in the company. Nisa Investment Advisors LLC bought a new position in Clarivate during the second quarter valued at about $26,000. Truist Financial Corp bought a new stake in Clarivate during the second quarter worth approximately $63,000. KBC Group NV grew its holdings in Clarivate by 33.2% during the third quarter. KBC Group NV now owns 10,225 shares of the company's stock valued at $73,000 after purchasing an additional 2,549 shares during the last quarter. Forum Financial Management LP bought a new position in shares of Clarivate in the second quarter valued at approximately $75,000. Finally, Headlands Technologies LLC lifted its stake in shares of Clarivate by 749.2% in the second quarter. Headlands Technologies LLC now owns 14,632 shares of the company's stock worth $83,000 after buying an additional 12,909 shares during the last quarter. Institutional investors own 85.72% of the company's stock.

Clarivate Price Performance

Shares of CLVT traded down $0.20 during mid-day trading on Tuesday, reaching $5.46. The company had a trading volume of 7,761,832 shares, compared to its average volume of 4,600,481. The company has a debt-to-equity ratio of 0.84, a current ratio of 0.88 and a quick ratio of 0.88. The company has a market capitalization of $3.88 billion, a P/E ratio of -2.74 and a beta of 1.12. Clarivate Plc has a twelve month low of $4.25 and a twelve month high of $9.60. The company's 50-day moving average is $5.94 and its 200-day moving average is $6.08.

Clarivate (NYSE:CLVT - Get Free Report) last issued its quarterly earnings data on Wednesday, November 6th. The company reported $0.19 earnings per share for the quarter, hitting the consensus estimate of $0.19. The firm had revenue of $622.20 million for the quarter, compared to analysts' expectations of $640.81 million. Clarivate had a negative net margin of 50.00% and a positive return on equity of 9.69%. The company's quarterly revenue was down 3.9% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.18 earnings per share. On average, equities analysts anticipate that Clarivate Plc will post 0.63 EPS for the current year.

Insider Transactions at Clarivate

In related news, insider Bar Veinstein sold 120,000 shares of Clarivate stock in a transaction dated Thursday, September 19th. The stock was sold at an average price of $7.00, for a total value of $840,000.00. Following the completion of the sale, the insider now directly owns 976,583 shares in the company, valued at $6,836,081. This trade represents a 10.94 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Michael J. Angelakis bought 1,500,000 shares of the business's stock in a transaction on Wednesday, November 20th. The shares were acquired at an average price of $5.11 per share, for a total transaction of $7,665,000.00. Following the completion of the transaction, the director now owns 1,500,000 shares in the company, valued at approximately $7,665,000. This trade represents a ∞ increase in their position. The disclosure for this purchase can be found here. Company insiders own 22.77% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on the stock. Royal Bank of Canada cut their target price on shares of Clarivate from $7.00 to $6.00 and set a "sector perform" rating for the company in a research report on Thursday, November 7th. Barclays lowered their target price on Clarivate from $5.00 to $4.00 and set an "underweight" rating on the stock in a report on Thursday, November 7th. Finally, William Blair cut Clarivate from an "outperform" rating to a "market perform" rating in a research report on Wednesday, November 6th. Two research analysts have rated the stock with a sell rating, three have given a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of "Hold" and an average price target of $7.25.

Clarivate Profile

Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications.